SNCA and Parkinson disease: For example, introduction of pathogenic mutation(s), including the A30P mutation in alpha-synuclein (SNCA)33,34 and NL-G-F/NL-F mutations in amyloid precursor protein (APP),35 is useful for disease modeling of Parkinson’s and Alzheimer’s diseases with high penetrance, respectively.